Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q4 2024 Earnings Call Transcript February 27, 2025
Ligand Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $1.27 EPS, expectations were $1.37.
Melanie Herman: Good morning everyone and welcome to Ligand’s Fourth Quarter and Full Year 2024 Earnings Call. During the call today, we will review the financial results we released earlier today and provide commentary on our partner pipeline and business development...
